Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07851844
Starting soon Observational

Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France

NCT07851844 · tracked via the Priya Life Science France tracker
Sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Started
2026-11-01
Last updated
2026-10-01

Condition(s) studied

Genetic and Inflammatory Polyneuropathies

Study summary

To describe the clinical, electrophysiological, and genetic characteristics of patients with genetic and inflammatory polyneuropathies in France.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients aged 18 years or older. * Patients with a diagnosis of genetic or inflammatory polyneuropathy, confirmed by complementary examinations performed as part of routine care, including genetic, biological and/or electrophysiological tests. Exclusion Criteria: \- Patient opposition to the use of their routine care data for research purposes.

Primary outcome measure(s)

  • Number and percentage of participants by type of polyneuropathy — At inclusion, based on the diagnosis documented in the medical record.
    Participants will be classified as having genetic or inflammatory polyneuropathy according to the diagnosis documented in their medical records. The number and percentage of participants in each category will be reported.

Trial sites (26)

FacilityCityRegionStatus
CHU Amiens-Picardie - Site Sud Amiens France
CHU Angers Angers France
Hôpital Pellegrin, CHU Bordeaux Bordeaux France
Hôpital Morvan, CHU Brest Brest France
Hôpital Pierre Wertheimer, HCL Bron France
Hôpital Gabriel-Montpied, CHU Clermont-Ferrand Clermont-Ferrand France
Hôpital François Mitterrand, CHU Dijon Dijon France
Centre Hospitalier Annecy Genevois Épagny France
Hôpital Raymond-Poincaré Garches France
CHU Grenoble - Site Sud Grenoble France
CHU de la Réunion - GH Sud Réunion - Saint-Pierre La Réunion France
Hôpital Bicêtre Le Kremlin-Bicêtre France
Hôpital Salengro, CHU de Lille Lille France
Hôpital Dupuytren, CHU Limoges Limoges France
Hôpital de la Timone, AP-HM Marseille France
F-Esselin@Chu-Montpellier.Fr Montpellier France
CHU Nantes - Hôtel-Dieu - Hôpital Mère-Enfant Nantes France
Hôpital Pasteur, CHU Nice Nice France
Hôpital Universitaire Carémeau, CHU Nîmes Nîmes France
Hôpital Ambroise Paré Paris France
Hôpital La Pitié-Salpetrière Paris France
Hôpital Maison Blanche, CHU Reims Reims France
Hôpital Charles-Nicolle, CHU Rouen Rouen France
Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg Strasbourg France
Hôpital Rangueil, CHU Toulouse Toulouse France
Hôpital Bretonneau CHRU de Tours Tours France

More Assistance Publique - Hôpitaux de Paris trials in France

Fusion Ultrasound for Diagnosis and Monitoring of Endometriosis Lesions Active, not recruiting
neonAtal motoR paTtErn autoMatIc analySis Recruiting
Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis Recruiting
Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic Shock Starting soon
Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07851844 on ClinicalTrials.gov ↗ ← All trials in France